Jinmei Yu

5PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 03, 2024
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.

Feng Wang, Yunxuan Li, Zhaona Yang

|Mar 25, 2021
Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.

Ke Li, Ting-Ting Zhang, Chen-Xi Zhao

|Dec 10, 2020
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.

Ke Li, Feng Wang, Zhao-Na Yang

|Jul 23, 2020
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target.

Jiao-Jiao Yu, Dan-Dan Zhou, Xiao-Xiao Yang

|Dec 18, 2019
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription.

Jin-Mei Yu, Wei Sun, Zhen-He Wang

Pageof 1

Frequent Collaborators

5 joint publications

Xiaowei Zhang

4 joint publications

Fang Hua

4 joint publications

Bing Cui

2 joint publications

Ke Li